Product Information

ENTECAVIR 1 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.3658 per EA under NDC 68382092106. Its NADAC has been published 438 times since Apr 4, 2018.

FDA first approved this application on Jun 23, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENTECAVIR 1 MG TABLET

Entecavir
$0.3658per EA

Strength

1 mg/1

NDC

68382092106

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ENTECAVIR

Approval Type

Generic (ANDA)

FDA Application

ANDA206745

FDA Approved

6/23/2017

TE Code

AB

On Market Since

8/10/2017

Pharmacological Classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Analog
Nucleoside Reverse Transcriptase Inhibitors

Price Statistics

The NADAC for ENTECAVIR 1 MG TABLET has been published 438 times since Apr 4, 2018, and over the history we have for it it has declined 92.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3658 per EA
All-time high$4.6637 (Apr 11, 2018)
All-time low$0.3119 (Feb 18, 2026)
52-week high$0.4888
52-week low$0.3119
Median price$0.9415
Average price$1.1545
Largest weekly change+93.7% (Jan 19, 2022)
Weeks tracked438
Tracking sinceApr 4, 2018

Price History

1W

+3.9%

1M

+3.9%

3M

+1.4%

6M

+17.3%

1Y

-18.8%

3Y

-27.3%

5Y

-75.3%

All

-92.2%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ENTECAVIR 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ENTECAVIR 1 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.3658 per EA (NDC 68382092106), effective Aug 19, 2026.

How has the price of ENTECAVIR 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for ENTECAVIR 1 MG TABLET has declined 92.2%. It has been tracked across 438 weekly CMS publications since Apr 4, 2018.

What are the highest and lowest recorded NADAC prices for ENTECAVIR 1 MG TABLET?

Since Apr 4, 2018, the NADAC for ENTECAVIR 1 MG TABLET has ranged from a low of $0.3119 (Feb 18, 2026) to a high of $4.6637 (Apr 11, 2018), with a median of $0.9415 per EA.

Are there cheaper alternatives to ENTECAVIR 1 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENTECAVIR 1 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ENTECAVIR 1 MG TABLET?

ENTECAVIR 1 MG TABLET (NDC 68382092106) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.